A Canadian study pinned a baby's death on codeine passed through breast milk. 20 years on, it's been retracted
The retracted research was a Canadian study linking a baby's death to codeine passed through breast milk. A leading medical journal withdrew it, saying omissions in the research amounted to “falsification.” The article does not name the journal or specify which information was omitted. The decision matters because the study was influential, not just a disputed claim in a journal. For about two decades, it informed guidance on breastfeeding and pain management around the world. A retraction means the journal has withdrawn the study as a reliable part of the published research record; it does not, by itself, explain every detail of what went wrong. The article gives no replacement study, revised guideline, or timeline for future changes. In general, professional groups may review guidance when important supporting research is withdrawn, but the retraction alone does not show what any group will change. The journal's stated reason—omissions amounting to falsification—also makes scrutiny of the study's evidence and reporting important.
What did the journal retract, and what reason did it give?
The retracted research was a Canadian study linking a baby's death to codeine passed through breast milk. A leading medical journal withdrew it, saying omissions in the research amounted to “falsification.” The article does not name the journal or specify which information was omitted.
The decision matters because the study was influential, not just a disputed claim in a journal. For about two decades, it informed guidance on breastfeeding and pain management around the world. A retraction means the journal has withdrawn the study as a reliable part of the published research record; it does not, by itself, explain every detail of what went wrong.
The article gives no replacement study, revised guideline, or timeline for future changes. In general, professional groups may review guidance when important supporting research is withdrawn, but the retraction alone does not show what any group will change. The journal's stated reason—omissions amounting to falsification—also makes scrutiny of the study's evidence and reporting important.
What did the study claim about codeine passing through breast milk and a baby's death?
The study's claim, as described in the source, was that codeine passed through breast milk and was linked to a baby's death. That connection drew attention because it concerned both infant safety and pain treatment for breastfeeding parents. The article does not give the baby's name, the study's specific evidence, or further details about the death.
As general medical context, a medicine taken by a breastfeeding parent can enter the bloodstream, and some amount may then reach breast milk. Codeine is also converted in the body into morphine. The amount and effects can vary, so a reported link should not automatically be treated as proof that codeine caused a particular death.
The source says the journal later retracted the study because omissions in the research amounted to “falsification.” That makes it especially important to distinguish the original study's reported link from a confirmed cause. The article does not state whether current guidance has changed or what conclusions later research reached. It establishes that the study had influenced guidance, then was withdrawn.
For how long, and how widely, did the study influence guidance on breastfeeding and pain management?
The Canadian study influenced global guidance on breastfeeding and pain management over the last two decades. In other words, its reach extended beyond the country where the study was conducted and lasted for roughly twenty years. The source does not name the specific guidelines, organizations, or countries involved.
That influence is notable because the study linked a baby's death to codeine passed through breast milk. Advice about pain medicine while breastfeeding can affect both a parent's treatment choices and how infant exposure is considered. The source does not describe the study's methods or explain precisely how its findings were used in each guideline.
The journal has now retracted the study, saying omissions in the research amounted to “falsification.” This challenges a piece of research that had helped inform guidance for a long period, but the source does not say that every guideline has been changed. The scale of any review, and what future recommendations will say, is not provided.
What can happen to medical guidance when influential research is retracted?
When influential research is retracted, medical guidance that relied on it may need to be checked. A retraction signals that a journal no longer stands behind the study as part of the published evidence. It does not automatically erase every recommendation linked to that study, because guidance may draw on several sources.
In this case, a Canadian study linked a baby's death to codeine passed through breast milk. It informed global guidance on breastfeeding and pain management over the last two decades. The journal retracted it after saying omissions in the research amounted to “falsification.” Those facts give guideline writers a reason to examine how much weight the study carried.
The source does not report any specific guideline changes or say what happens next. In general, experts and health organizations can reassess recommendations against the remaining evidence and issue updates when warranted. The practical result may depend on what other research supports the advice. So a retraction can trigger review, but it does not alone establish the right replacement recommendation.
Why can leaving out important information in a study amount to falsification?
Omission can distort a research report when the missing information is important to interpreting its results. Readers may come away with a different picture of what the evidence shows if relevant findings, methods, or limitations are left out. In the source, the journal said the omissions in the Canadian study amounted to “falsification.”
For example, leaving out information that weakens or contradicts a conclusion could make that conclusion appear more certain than the full record supports. That is a general illustration, not a claim about what this study omitted: the source does not identify the missing information. The key issue is whether what was left out materially changed how the research should be understood.
The journal's stated reason explains why the retraction matters, but the source does not provide the journal's detailed findings or say whether anyone intended to mislead. A retraction withdraws the study from the trusted research record; it does not, by itself, tell readers every detail of the problem. Understanding those details would require the journal's fuller explanation.
What is codeine, and why can different people process it into morphine at different rates?
Codeine is an opioid medicine used to relieve pain. The body converts some codeine into morphine, which contributes to its pain-relieving effect. This basic drug information is general medical knowledge; the source article only identifies codeine and its passage through breast milk.
A major reason people can process codeine differently is variation in the inherited CYP2D6 enzyme system. Some people convert codeine to morphine more slowly, while others convert it more quickly. Faster conversion can produce more morphine from a given amount of codeine. The source does not discuss genes, enzymes, or the metabolism of codeine.
These differences matter when considering how a medicine may affect a breastfeeding parent or infant, but they do not determine an individual outcome by themselves. The article reports that the study linking a baby's death to codeine in breast milk informed guidance for about two decades, and was later retracted for omissions described as falsification. This explanation of metabolism is broader context, not a finding from that study.
How can a medicine taken by a breastfeeding parent reach an infant through breast milk, and what affects the amount?
After a breastfeeding parent takes a medicine, it may be absorbed into the bloodstream. Some drugs can then pass from blood into breast milk, which an infant may consume during feeding. This is general medical context; the source article specifically says codeine passed through breast milk in the study's reported link to a baby's death.
How much reaches milk can vary. In general, factors include the medicine's dose, how it is absorbed and broken down, its properties, and the timing of a dose relative to feeding. How much milk an infant takes and the infant's ability to process a drug can also affect exposure and response. These factors are not detailed in the source article.
The source reports that the study informed global guidance on breastfeeding and pain management for about two decades, before a leading journal retracted it over omissions it called “falsification.” It does not provide current advice on codeine or say what guidance will replace the study. The general mechanism helps explain why medicine and breastfeeding questions require careful assessment.
This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.
Read more in the JupiteX app
Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.
Or read more news on the web